Adcytherix raises €105 million in Series A funding led by Bpifrance to accelerate the development of its next-generation antibody-drug conjugates.
Amount Raised
€105 Million
Round Type
Series A
MarseilleBiotechnologyHealth CareresearchInvestors
Description
Adcytherix SAS has successfully closed a €105 million Series A funding round led by Bpifrance, co-directed by Kurma Partners, Andera Partners, and Angelini Ventures. This funding positions the company as a key player in the ADC space and will support advancing its ADCX-020 candidate towards clinical trials. The company aims to file regulatory submissions in the US and Europe by the end of 2025. The round also saw participation from a consortium of prominent international investors, ensuring robust support for their innovative therapies.
Quick answer
Adcytherix raised €105 Million in a Series A round, dated October 16, 2025. Investors: aMoon, Surveyor Capital, A Moon, Bpifrance, Kurma Partners, Andera Partners and Angelini Ventures. Adcytherix is based in Marseille, Provence Alpes Côte D'azur, France.
- How much did Adcytherix raise?
- Adcytherix raised €105 Million in a Series A round on October 16, 2025.
- Who invested in Adcytherix?
- aMoon, Surveyor Capital, A Moon, Bpifrance, Kurma Partners, Andera Partners and Angelini Ventures are named as investors in this round.
- What does Adcytherix do?
- Adcytherix is a biopharmaceutical company focused on the development of novel antibody-drug conjugates (ADC) to treat high unmet need diseases such as cancer.
- Where is Adcytherix based and how big is it?
- Adcytherix is based in Marseille, Provence Alpes Côte D'azur, France. Fundz records about 9 employees.
- Who are the decision-makers at Adcytherix?
- Fundz holds 3 contacts at Adcytherix, including the Chief Financial Officer - CFO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in research and Biotechnology around the same time
Companies in the same sectors as Adcytherix that raised within 45 days of this round, from Fundz verified event records.
- Brainstorm Cell Therapeutics raised $155K (Convertible Note) on November 6, 2025.
- Hepta raised $6.7M (Seed) on November 5, 2025.
- AAVantgarde Bio raised $141M (Series B) on November 3, 2025.
- Faeth Therapeutics raised $25M (Funding Round) on October 20, 2025.
- Cyclana Bio raised $6.7M (Pre-Seed) on October 20, 2025.
- Grail raised $325M (Post-IPO Equity) on October 20, 2025.
Who to call at Adcytherix, and when
A new round usually means Adcytherix is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Adcytherix raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Adcytherix, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Adcytherix. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Adcytherix raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAdcytherix raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.